World Allergy Organization Journal (Aug 2021)
Atopic dermatitis in the COVID-19 era: Results from a web-based survey
- Natalia Hernández,
- Gloria Sanclemente,
- Liliana Tamayo,
- Ángela López,
- Angela Seidel,
- Natalia Hernandez,
- Gloria Sanclemente,
- Daniela Chaparro,
- Ángela López,
- Andrés Cortes,
- Ángela Seidel,
- Clara Inés Ortiz,
- Claudia Arenas,
- Esperanza Meléndez,
- Julio Amador,
- Liliana Tamayo,
- Lina Colmenares,
- María Claudia Guzmán,
- María Claudia Torres,
- Mariela Tavera,
- Mauricio Torres,
- Miriam Vargas,
- Mónica Novoa,
- Mónica Rivera,
- Natalia Vélez,
- Oscar Mora,
- Oscar Medina,
- Paola Cárdenas
Affiliations
- Natalia Hernández
- Dermatosoluciones SAS, Location Address: Calle 90 # 19A 49 Cons 501, Bogotá, Colombia
- Gloria Sanclemente
- Group of Investigative Dermatology (GRID), University of Antioquia, Medellín, Colombia; Corresponding author. Group of Investigative Dermatology (GRID) School of Medicine, University of Antioquia, Carrera 25 A # 1 A Sur 45, Of 1247, Torre Médica 2, El Tesoro, Medellín, Colombia.
- Liliana Tamayo
- Universidad Pontificia Bolivariana, Medellín, Colombia
- Ángela López
- IPS Fototerapia Bojanini y López SAS, Bogotá, Colombia
- Angela Seidel
- Clínica Central del Quindío, Colombia
- Natalia Hernandez
- Dermatosoluciones SAS, Colombia
- Gloria Sanclemente
- Group of Investigative Dermatology (GRID), University of Antioquia, Medellin, Colombia
- Daniela Chaparro
- Pontificia Universidad javeriana, Bogota, Colombia
- Ángela López
- IPS Fototerapia Bojanini y López SAS, Colombia
- Andrés Cortes
- Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia
- Ángela Seidel
- Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia
- Clara Inés Ortiz
- Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia
- Claudia Arenas
- Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia
- Esperanza Meléndez
- Hospital Universidad del Norte, Barranquilla, Colombia
- Julio Amador
- Universidad Militar, Bogotá, Colombia
- Liliana Tamayo
- Universidad Pontificia Bolivariana, Medellín, Colombia
- Lina Colmenares
- Universidad CES, Medellín, Colombia
- María Claudia Guzmán
- Fundación Ciencias de la Salud, Bogotá, Colombia
- María Claudia Torres
- Fundación Ciencias de la Salud, Bogotá, Colombia
- Mariela Tavera
- Fundación Ciencias de la Salud, Bogotá, Colombia
- Mauricio Torres
- Fundación Ciencias de la Salud, Bogotá, Colombia
- Miriam Vargas
- Universidad del valle, Cali, Colombia
- Mónica Novoa
- Fundación Ciencias de la Salud, Bogotá, Colombia
- Mónica Rivera
- Universidad CES, Medellín, Colombia
- Natalia Vélez
- Universidad CES, Medellín, Colombia
- Oscar Mora
- Fundación Ciencias de la Salud, Bogotá, Colombia
- Oscar Medina
- Dermatosoluciones SAS, Colombia; Group of Investigative Dermatology (GRID), University of Antioquia, Medellin, Colombia; Pontificia Universidad javeriana, Bogota, Colombia; IPS Fototerapia Bojanini y López SAS, Colombia; Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia; Hospital Universidad del Norte, Barranquilla, Colombia; Universidad Militar, Bogotá, Colombia; Universidad Pontificia Bolivariana, Medellín, Colombia; Universidad CES, Medellín, Colombia; Fundación Ciencias de la Salud, Bogotá, Colombia; Universidad del valle, Cali, Colombia; Universidad CES, Medellín, Colombia
- Paola Cárdenas
- Dermatosoluciones SAS, Colombia; Group of Investigative Dermatology (GRID), University of Antioquia, Medellin, Colombia; Pontificia Universidad javeriana, Bogota, Colombia; IPS Fototerapia Bojanini y López SAS, Colombia; Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia; Hospital Universidad del Norte, Barranquilla, Colombia; Universidad Militar, Bogotá, Colombia; Universidad Pontificia Bolivariana, Medellín, Colombia; Universidad CES, Medellín, Colombia; Fundación Ciencias de la Salud, Bogotá, Colombia; Universidad del valle, Cali, Colombia; Universidad CES, Medellín, Colombia
- Journal volume & issue
-
Vol. 14,
no. 8
p. 100571
Abstract
Given that the COVID-19 era has changed the behavior of all individuals, and since previous reports about its possible impact on atopic dermatitis (AD) patients remained speculative, in this survey we aimed to explore the real impact of COVID-19 among AD patients.All participants provided verbal consent prior to completing the survey. A 37-question web-based survey with no personal identifiers was sent to 212 previously identified AD patients. Itching, sleep disturbances, SARS-CoV-2, illness cost, economic dependence, monthly income, and monthly investment in AD before and during the pandemic, were all included in the analysis.A response rate of 73.1% was obtained. The mean age of participants was 30 years-old, and 57% were women. Around 75% reported AD worsening, and 59.4% of the patients reported sleep problems. Uncertainty, anxiety, and pessimism were frequent during the pandemic. Only 1.3% tested positive for SARS-CoV-2, and it was only significantly associated with comorbidities (p=0.03; Chi2 Test). A significant difference was found in economic dependence and monthly income when compared between before and during the pandemic.This study provides probably the best possible assessment of the clinical, social, and economic effects of the pandemic on patients with an already proven diagnosis of AD.
